Remedium Lifecare Ltd (539561) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539561 | NSE: | Trading | Small Cap

Remedium Lifecare Share Price

0.95 -0.04 -4.04%
as on 05-Dec'25 12:12

Remedium Lifecare Ltd (539561) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 539561 | NSE: | Trading | Small Cap

DeciZen - make an informed investing decision on Remedium Lifecare

Based on:

M-Cap below 100cr DeciZen not available

Remedium Lifecare stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
87.3 Cr.
52-wk low:
0.8
52-wk high:
4.3

Is Remedium Lifecare Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Remedium Lifecare: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Remedium Lifecare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 0.7%0.1%0.6%0.6%11.2%7.4%18.2%102.5%99.5%1.8%-
Value Creation
Index
-1.0-1.0-1.0-1.0-0.2-0.50.36.36.1-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 3.91.30.40.22.9905055104,042223147
Sales YoY Gr.--66.2%-73.7%-54.3%1,706.3%3,015.2%460.7%1%692.7%-94.5%-
Adj EPS 00000000.10.3-0.1-0
YoY Gr.-NANANANANA100%300%287.5%-132.3%-
BVPS (₹) 0.10.10.10.10.10.10.10.20.70.81
Adj Net
Profit
00000.30.51.14.918-5.9-2
Cash Flow from Ops. -1.40.1-0.2-0.1-0.2-10.211.320.5-74.2-1,079-
Debt/CF from Ops. -000-1.1-1.8-100-0.8-1.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 56.6%138.4%-23.9%-94.5%
Adj EPS NANA-271%-132.3%
BVPS35.1%65.7%102.7%1.4%
Share Price - 39.5% 2.6% -75.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
0.30.10.50.28.413.324.563.467.7-13.8-2.3
Op. Profit
Mgn %
-7.6-7.40.2-43.213.40.80.41.40.90.2-9.4
Net Profit
Mgn %
0.20.33.93.99.40.50.210.5-2.7-1.2
Debt to
Equity
00000.12.7001.326.412
Working Cap
Days
4151,0503,2436,36635182944851392,8584,398
Cash Conv.
Cycle
3258012,1892,045110101727211,0383,071

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Remedium Lifecare Ltd.

Standalone Consolidated
TTM EPS (₹) -0 0
TTM Sales (₹ Cr.) 147 405
BVPS (₹.) 1 1.2
Reserves (₹ Cr.) 3 17
P/BV 0.96 0.83
PE 0.00 41.01
From the Market
52 Week Low / High (₹) 0.80 / 4.28
All Time Low / High (₹) 0.07 / 31.35
Market Cap (₹ Cr.) 87.3
Equity (₹ Cr.) 88.2
Face Value (₹) 1
Industry PE 36.9

Management X-Ray of Remedium Lifecare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Remedium Lifecare - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Remedium Lifecare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales3.931.330.350.162.8990.03504.79509.844,041.71222.50
Operating Expenses 4.231.430.350.232.5089.31502.98502.674,007.51221.96
Manufacturing Costs0.590.790.020.010.130.211.741.741.011.42
Material Costs3.390.460.140.051.6787.74498.47493.864,001.38216.11
Employee Cost 0.050.040.130.040.180.190.210.550.400.41
Other Costs 0.210.140.060.130.521.172.566.524.724.02
Operating Profit -0.30-0.100-0.070.390.721.827.1734.190.54
Operating Profit Margin (%) -7.6%-7.4%0.2%-43.2%13.4%0.8%0.4%1.4%0.8%0.2%
Other Income 0.330.100.020.090.010.010.010.8321.1010.80
Interest 0.010000.010.020.230.454.787.64
Depreciation 0.010000.010.060.070.150.060.04
Exceptional Items 0000000000
Profit Before Tax 0.0100.020.020.380.651.537.4050.453.66
Tax 0000.010.100.170.451.9717.722.13
Profit After Tax 0.0100.010.010.280.481.085.4332.731.53
PAT Margin (%) 0.3%0.3%3.9%5.0%9.6%0.5%0.2%1.1%0.8%0.7%
Adjusted EPS (₹)0.00.00.00.00.00.00.00.10.60.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3.043.043.073.083.353.864.9410.3642.9643.30
Share Capital 3.603.603.603.603.603.603.603.6010.0840.32
Reserves -0.56-0.56-0.53-0.52-0.250.261.346.7632.882.98
Minority Interest0000000000
Debt0000.080.3610.500057.701,141.39
Long Term Debt0000.080.3610.500000
Short Term Debt0000000057.701,141.39
Trade Payables1.37000.350.3923.77124.5684.22712.29320.98
Others Liabilities 0.160.250.060.020.160.4094.261,059.631,134.9533.94
Total Liabilities 4.573.293.133.534.2738.53223.761,154.221,947.901,539.61

Fixed Assets

Gross Block0.210.210.2100.240.290.340.200.220.22
Accumulated Depreciation0.190.190.2000.010.080.150.120.180.22
Net Fixed Assets 0.020.010.0100.230.210.190.080.050.01
CWIP 0000000000
Investments 0000000000.07
Inventories0.83000.200.703.1183.877.32133.23269.38
Trade Receivables2.852.172.030.141.5023.6864172.37920.60590.92
Cash Equivalents 0.010.160.021.080.930.811.4421.861.521.36
Others Assets 0.860.951.072.110.9110.7274.27952.59892.49677.88
Total Assets 4.573.293.133.534.2738.53223.761,154.221,947.901,539.61

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.360.07-0.16-0.07-0.20-10.2111.2820.50-74.16-1,078.63
PBT 0.0100.020.010.380.651.537.4050.453.66
Adjustment -0.05-0.090-0.090.010.060.180.193.845.20
Changes in Working Capital -1.320.15-0.170-0.59-10.8910.0314.89-110.64-1087
Tax Paid -0-0-00.010-0.04-0.45-1.98-17.81-0.49
Cash Flow From Investing Activity 1.480.090.021.06-0.24-0.04-0.05-0.040.090.06
Capex 1.41000.02-0.24-0.04-0.05-0.0400
Net Investments 0000000000
Others 0.070.090.021.0400000.090.06
Cash Flow From Financing Activity -0.11-0-00.080.2910.14-10.61-0.0453.741,078.40
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -0.10-0000.2910.14-10.50000
Interest Paid -0.01-0-0000-0.11-0.04-3.87-5.29
Dividend Paid 0000000000
Others -0000.08000057.611,083.69
Net Cash Flow 00.15-0.141.06-0.15-0.110.6220.42-20.33-0.16

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)0.360.110.450.268.6213.3324.5170.92122.763.55
ROCE (%)0.660.140.550.6211.167.3918.16102.5499.511.76
Asset Turnover Ratio0.760.340.110.050.744.213.850.742.610.13
PAT to CFO Conversion(x)-136N/A-16-7-0.71-21.2710.443.78-2.27-704.99
Working Capital Days
Receivable Days2246882,1892,487103513285491,240
Inventory Days1000047057831336330
Payable Days0001,4268150547736873

Remedium Lifecare Ltd Stock News

Remedium Lifecare Ltd FAQs

The current trading price of Remedium Lifecare on 05-Dec-2025 12:12 is ₹0.95.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Remedium Lifecare stood at ₹87.32.
The latest P/E ratio of Remedium Lifecare as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Remedium Lifecare as of 04-Dec-2025 is 0.96.
The 52-week high of Remedium Lifecare is ₹4.28 and the 52-week low is ₹0.80.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Remedium Lifecare is ₹146.7 ( Cr.) .

About Remedium Lifecare Ltd

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. The company has made a paradigm shift by entering into the manufacturing of intermediates and APIs and be reckoned as a leading contract manufacturer and as a brand owner of advanced intermediates & APIs. The strategic acquisition of the state-of-the-art manufacturing facilities in Hyderabad, was a timely move to forward integrate and diversify into the pharma & healthcare arena. A massive facility with 2 dedicated manufacturing blocks is now ready for large scale manufacture.

The company is engaged into the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Amino isophthalic Acid, Tellurium (IV) Oxide, Grignard Reagent, lodine, Selenium Metal Powder, Trimethyl Sulfoxonium lodide (TMSI).

Business area of the company

The company is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×